• Users Online: 298
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
CASE SERIES
Year : 2019  |  Volume : 11  |  Issue : 2  |  Page : 109-114

Management of periarthritis of shoulder joint by suprascapular nerve block


Department of Orthopaedics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India

Correspondence Address:
Prof. Buddhadeb Nayak
Room No.B107, Resident Hostel, All India Institute of Medical Sciences Campus, Tatibandh, Raipur - 492 099, Chhattisgarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jotr.jotr_38_19

Rights and Permissions

Introduction: Periarthritis of the shoulder is a condition characterized by painful and global restriction of active and passive glenohumeral range of motion in at least two directions, most notably shoulder abduction and external rotation. Therapeutic options for the management of periarthritis shoulder are as follows: nonsteroidal anti-inflammatory drugs, intra-articular steroid injections, suprascapular nerve block (SSNB), platelet-rich plasma injection, manipulation under general anesthesia, or arthroscopic capsular release. SSNB is an old and effective method for the treatment of periarthritis of shoulder. Recently, ultrasonography (USG)-guided nerve blocks have been found to be safer and more efficacious compared to landmark guided nerve blocks. In this case series, SSNB has been done under USG guidance to check for its efficacy. Aim: This study aims to assess the efficacy of SSNB in the treatment of periarthritis of the shoulder joint. Materials and Methods: Patients with periarthritis of shoulder received single injection of SSNB (n = 20) (40 mg methylprednisolone + 5 ml 2% lignocaine). All participants were also advised to perform a home-based 10 min exercise therapy after injection. The outcome was measured using Constant and Murley shoulder score. Participants were evaluated at 0, 3rd day, and 1 month. Unpaired t-test was used to determine significant differences. Results: SSNB treatment resulted in statistically significant improvements in CONSTANT score on both 3rd day and 1-month follow-up. No major adverse effects were seen in SSNB. Conclusion: This study demonstrates that single injection of SSNB improves both in pain and all range of motion of shoulder joint.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed81    
    Printed0    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal